Phase II study of gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples